178 related articles for article (PubMed ID: 21116237)
1. Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.
Wrench D; Montoto S
Nat Rev Clin Oncol; 2010 Dec; 7(12):677-8. PubMed ID: 21116237
[No Abstract] [Full Text] [Related]
2. Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites.
Hiroshima Y; Tajima K; Shiono Y; Suzuki I; Kouno K; Yamamoto M; Kato Y; Kato T
Ann Hematol; 2012 Sep; 91(9):1499-500. PubMed ID: 22281990
[No Abstract] [Full Text] [Related]
3. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
4. Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.
Seymour JF
Nat Rev Clin Oncol; 2009 Nov; 6(11):624-6. PubMed ID: 19861993
[No Abstract] [Full Text] [Related]
5. A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma.
Marcus R; Aultman R; Jost F
Br J Cancer; 2010 Jan; 102(1):19-22. PubMed ID: 19920818
[TBL] [Abstract][Full Text] [Related]
6. Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.
Vidal L; Gafter-Gvili A; Salles G; Bousseta S; Oberman B; Rubin C; van Oers MH; Fortpied C; Ghielmini M; Pettengell R; Witzens-Harig M; Dreger P; Vitolo U; Gomes da Silva M; Evangelista A; Li H; Freedman L; Habermann TM; Shpilberg O
Eur J Cancer; 2017 May; 76():216-225. PubMed ID: 28336303
[TBL] [Abstract][Full Text] [Related]
7. Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
Gopal AK; Kahl BS; Flowers CR; Martin P; Ansell SM; Abella-Dominicis E; Koh B; Ye W; Barr PM; Salles GA; Friedberg JW
Blood; 2017 Jun; 129(22):3037-3039. PubMed ID: 28325864
[No Abstract] [Full Text] [Related]
8. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.
van Oers MH; Van Glabbeke M; Giurgea L; Klasa R; Marcus RE; Wolf M; Kimby E; van t Veer M; Vranovsky A; Holte H; Hagenbeek A
J Clin Oncol; 2010 Jun; 28(17):2853-8. PubMed ID: 20439641
[TBL] [Abstract][Full Text] [Related]
9. Relative dose intensity of R-CHOP therapy and patient outcomes in advanced follicular lymphoma.
Konishi T; Kanemasa Y; Sasaki Y; Okuya T; Yamaguchi T; Funasaka C; Shimoyama T; Omuro Y
Hematol Oncol; 2019 Aug; 37(3):303-307. PubMed ID: 30933366
[No Abstract] [Full Text] [Related]
10. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
[No Abstract] [Full Text] [Related]
11. Follicular lymphoma: 2012 update on diagnosis and management.
Freedman A
Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
[TBL] [Abstract][Full Text] [Related]
12. [Systemic follicular lymphoma with cutaneous manifestations and exclusively cutaneous recurrence].
Palacios Abufón A; Acebo Mariñas E; Gardeazabal García J; García-Ruiz JC
Actas Dermosifiliogr; 2012 Apr; 103(3):253-5. PubMed ID: 22093542
[No Abstract] [Full Text] [Related]
13. Rituximab maintenance versus retreatment in follicular lymphoma.
Palla AR; Hamadani M
Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
[TBL] [Abstract][Full Text] [Related]
14. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
Lazzarino M; Arcaini L; Bernasconi P; Alessandrino EP; Gargantini L; Cairoli R; Orlandi E; Astori C; Brusamolino E; Pagnucco G; Colombo AA; Calatroni S; Iacona I; Regazzi MB; Morra E
Br J Haematol; 2002 Jan; 116(1):229-35. PubMed ID: 11841421
[TBL] [Abstract][Full Text] [Related]
15. Aggressive lymphoma: improving treatment outcome with rituximab.
Coiffier B; Pfreundschuh M; Stahel R; Vose J; Zinzani PL
Anticancer Drugs; 2002 Nov; 13 Suppl 2():S43-50. PubMed ID: 12710590
[TBL] [Abstract][Full Text] [Related]
16. [Advances in management of follicular lymphoma].
Zinzani PL
Rinsho Ketsueki; 2014 Oct; 55(10):1937-40. PubMed ID: 25297758
[No Abstract] [Full Text] [Related]
17. Retrospective study of the utility of FLIPI/FLIPI-2 for follicular lymphoma patients treated with R-CHOP.
Numata A; Tomita N; Fujimaki K; Tanaka M; Hashimoto C; Oshima R; Matsumoto K; Matsuura S; Yamamoto W; Motomura S; Ishigatsubo Y
J Clin Exp Hematop; 2012; 52(1):77-9. PubMed ID: 22706536
[No Abstract] [Full Text] [Related]
18. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.
Arcaini L; Montanari F; Alessandrino EP; Tucci A; Brusamolino E; Gargantini L; Cairoli R; Bernasconi P; Passamonti F; Bonfichi M; Zoli V; Bottelli C; Calatroni S; Troletti D; Merli M; Pascutto C; Majolino I; Rossi G; Morra E; Lazzarino M
Ann Oncol; 2008 Jul; 19(7):1331-1335. PubMed ID: 18344536
[TBL] [Abstract][Full Text] [Related]
19. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL
Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128
[No Abstract] [Full Text] [Related]
20. Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas.
Domingo-Domènech E; González-Barca E; Estany C; Sureda A; Besalduch J; Fernández de Sevilla A
Haematologica; 2002 Nov; 87(11):1229-30. PubMed ID: 12414357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
